Peritoneal dialysis fluid testing system

Information

  • Patent Grant
  • 11679186
  • Patent Number
    11,679,186
  • Date Filed
    Monday, March 15, 2021
    3 years ago
  • Date Issued
    Tuesday, June 20, 2023
    10 months ago
Abstract
The invention relates to a testing system and related methods for detecting peritonitis or infection in peritoneal dialysate removed from a patient. The testing system can include a fluid sensor apparatus in a fluid line of a peritoneal dialysis cycler through which spent peritoneal dialysate can be pumped. The fluid sensor apparatus can detect one or more markers associated with peritonitis or infection.
Description
FIELD OF THE INVENTION

The invention relates to a testing system and related methods for detecting peritonitis or infection in peritoneal dialysate removed from a patient. The testing system can include a fluid sensor apparatus in a fluid line of a peritoneal dialysis cycler through which spent peritoneal dialysate can be pumped. The fluid sensor apparatus can detect one or more markers associated with peritonitis or infection.


BACKGROUND

Peritoneal Dialysis (PD), including Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD), is a dialysis treatment that can be performed at home, either by the patient alone or with a care-giver. PD differs from Hemodialysis (HD) in that blood is not removed from the body and passed through a dialyzer, but rather a catheter is placed in the peritoneal cavity and dialysate introduced directly into the peritoneal cavity. Blood is cleaned inside the patient using the patient's own peritoneum as a type of dialysis membrane. However, because fluid is directly introduced into a human body, the fluid used for peritoneal dialysate is generally required to be free of biological and chemical contaminants. Due to the risk of infection by PD patients, continuous monitoring is required.


Current methods of diagnosing peritonitis or infection in PD patients involves the patient checking the used peritoneal dialysate for cloudiness or discoloration, and if the used peritoneal dialysate is cloudy or discolored, testing the used peritoneal dialysate at a clinic. Cloudiness or discoloration, however, can have several causes other than infection, and as such, the current methods result in many false positives, leading to expensive testing and treatment of otherwise healthy individuals. Testing can increase the time between the onset of infection and the beginning of treatment for the infection. Visual inspection and other known means of testing may not be dispositive.


Hence, there is a need for systems and methods that can test spent peritoneal dialysate for infection or peritonitis without the need to send the spent peritoneal dialysate to a clinic. There is a further need for systems and methods that can automatically, accurately, and correctly test and analyze the spent peritoneal dialysate, eliminating the need for individual patients to conduct visual inspections. The need extends to systems and methods that can quickly and dispositively determine whether a patient has peritonitis or an infection.


SUMMARY OF THE INVENTION

The first aspect of the invention is drawn to a system. In any embodiment, the system can comprise a peritoneal dialysis cycler; the peritoneal dialysis cycler comprising a catheter for removing peritoneal dialysate from a patient, at least one fluid line fluidly connected to the catheter; a pump; and a fluid sensor apparatus; the fluid sensor apparatus fluidly connected to the fluid line; the fluid sensor apparatus detecting at least one fluid characteristic in fluid removed from the patient; and a processor, the processor programmed to identify peritonitis and/or infection based on the at least one fluid characteristic.


In any embodiment, at least one fluid characteristic can comprise at least one marker correlated with peritonitis and/or infection.


In any embodiment, the fluid sensor apparatus can comprise: at least one fluid inlet fluidly connected to the fluid line and at least one fluid outlet fluidly connected to a second fluid line; a receiving slot for a sensor card; the receiving slot fluidly connected to the fluid inlet and fluid outlet; a light source directing light onto a first side of the sensor card; and a camera or photodetector detecting light on a second side of the sensor card opposite to the first side of the sensor card; the camera or photodetector in communication with a processor, the processor programmed to identify peritonitis and/or infection based on the at least one fluid characteristic.


In any embodiment, the sensor card can comprise at least one sensor region; the at least one sensor region undergoing a detectable change in response to at least one marker correlated with peritonitis and/or infection.


In any embodiment, the sensor card can comprise at least two sensor regions; wherein a first sensor region undergoes a detectable change in response to a first marker correlated with peritonitis and/or infection; and wherein a second sensor region undergoes a detectable change in response to a second marker correlated with peritonitis and/or infection.


In any embodiment, the at least one marker can be selected from a group consisting of MMP8, IL-6, HNE, MMP2, MMP9, TIMP1, TIMP2, NGAL, A1AT, desmosine, fibrinogen, IL-8, calprotectin, fMLP, IL1 b, cystatin C, HSA, RBP4, SPD, MPO, sICAM and TNFa.


In any embodiment, the system can comprise a bypass line fluidly connecting the fluid line upstream of the fluid sensor apparatus to the second fluid line downstream of the fluid sensor apparatus.


In any embodiment, the second fluid line can be fluidly connected to a drain and/or to a waste reservoir.


In any embodiment, the catheter can be a dual lumen catheter.


In any embodiment, the catheter can comprise at least one side slot.


In any embodiment, the at least one fluid characteristic can comprise at least one of a color and/or a clarity of the fluid.


Any of the features disclosed as being part of the first aspect of the invention can be included with any other feature of the first aspect of the invention, either alone or in any combination or sub-combination with the other features.


The second aspect of the invention is drawn to a method. In any embodiment, the method can comprise pumping a peritoneal dialysate from a peritoneal cavity of a patient through a catheter to a fluid sensor apparatus; and detecting at least one fluid characteristic of the peritoneal dialysate correlated with peritonitis and/or infection.


In any embodiment, the fluid sensor apparatus can comprise at least one fluid inlet fluidly connected to the catheter and at least one fluid outlet fluidly connected to a second fluid line; wherein fluid is pumped through the fluid sensor apparatus from the inlet to the outlet; a receiving slot for a sensor card; the receiving slot in fluid communication with the fluid inlet and fluid outlet; a light source directing light onto a first side of the sensor card; and a camera or photodetector detecting light on a second side of the sensor card opposite to the first side of the sensor card; wherein the step of detecting at least one fluid characteristic of the peritoneal dialysate comprises the steps of directing light from the light source onto a first side of the sensor card and detecting the light on a second side of the sensor card.


In any embodiment, peritoneal dialysate can be pumped from the peritoneal cavity of the patient through the fluid sensor apparatus during a dwell period.


In any embodiment, peritoneal dialysate can be pumped from the peritoneal cavity of the patient through the fluid sensor apparatus during a drain portion of a peritoneal dialysis cycle.


In any embodiment, the at least one fluid characteristic can be one or more markers correlated with peritonitis and/or infection.


In any embodiment, the method can comprise the step of diagnosing the patient with peritonitis and/or infection based on the at least one fluid characteristic.


In any embodiment, the step of diagnosing the patient with peritonitis and/or infection can be performed by a processor in communication with the fluid sensor apparatus.


In any embodiment, the one or more markers associated with peritonitis and/or infection can be selected from a group consisting of MMP8, IL-6, HNE, MMP2, MMP9, TIMP1, TIMP2, NGAL, A1AT, desmosine, fibrinogen, IL-8, calprotectin, fMLP, IL1 b, cystatin C, HSA, RBP4, SPD, MPO, sICAM and TNFa.


In any embodiment, the at least one fluid characteristic of the peritoneal dialysate can comprise at least one of a color and a clarity of the fluid.


Any of the features disclosed as being part of the second aspect of the invention can be included with any other feature of the second aspect of the invention, either alone or in any combination or sub-combination with the other features.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a peritoneal dialysis cycler with a fluid sensor apparatus.



FIGS. 2A-F show a side, perspective, and top view of a fluid sensor apparatus.



FIG. 3 illustrates a sensor card for use with the fluid sensor apparatus.



FIG. 4 illustrates a non-limiting example of a catheter for use with the peritoneal dialysate fluid testing system.





DETAILED DESCRIPTION OF THE INVENTION

Unless defined otherwise, all technical and scientific terms used herein generally have the same meaning as commonly understood by one of ordinary skill in the relevant art.


The articles “a” and “an” are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example, “an element” means one element or more than one element.


A “bypass line” can be a fluid line in a flow path that can allow fluid or fluid flow in, for example, a main line, to move around or avoid one or more components or portions of the flow path, and then optionally, rejoin the main line.


A “camera” is a component capable of creating a digital representation of light intensity, light composition, or both.


A “catheter” can be any tube or fluid line comprising any number of lumens through which fluids or fluid flow can pass through. The catheter can be used to add or remove fluids or fluid flow from a body of a patient. The catheter can be inserted into a body cavity for introducing or withdrawing fluid of any type. The catheter can be rigid, flexible, or semi-flexible and can be constructed of any suitable material known in the art.


The term “clarity” refers to an amount of radiant light or energy shined on a fluid that can pass through the fluid.


The term “color” refers to a wavelength of light reflected from or transmitted through a component, fluid, substance, compound, or feature.


The terms “communication” or “electronic communication” refer to the ability to transmit electronic information between two components or systems.


The term “comprising” includes, but is not limited to, whatever follows the word “comprising.” Thus, use of the term indicates that the listed elements are required or mandatory but that other elements are optional and may or may not be present.


The term “consisting of” includes and is limited to whatever follows the phrase “consisting of.” Thus, the phrase indicates that the limited elements are required or mandatory and that no other elements may be present.


The term “consisting essentially of” includes whatever follows the term “consisting essentially of” and additional elements, structures, acts or features that do not affect the basic operation of the apparatus, structure or method described.


A “dual lumen catheter” is a catheter having two fluid passageways for moving fluid through the catheter in both directions.


A “detectable change” is any change in color, optical transmittance, or change emitted fluorescent light intensity or wavelength in a sensor region.


The terms “detecting,” “detected,” or “to detect” refer to determining a state or characteristic of any variable, system, or system. For example, a fluid characteristic or parameter can be detected by a sensor detecting that particular fluid characteristic or parameter.


The term “detecting light” or to “detect light” means to measure a wavelength or intensity of light.


The term “diagnosing” or to “diagnose” means to determine whether a patient has a specified illness or condition.


The term “directing light” or to “direct light” refer to causing light to move in a specified path or to a specified location.


The term “downstream” refers to a position of a first component in a flow path relative to a second component wherein fluid will pass by the second component prior to the first component during normal operation. The first component can be said to be “downstream” of the second component, while the second component is “upstream” of the first component.


A “drain” is a fluid line through which fluids may be disposed.


A “drain portion of a peritoneal dialysis cycle” is a time during peritoneal dialysis during which peritoneal dialysate is removed from the peritoneal cavity of a patient.


The term “dwell period” refers to a time during a peritoneal dialysis cycle wherein peritoneal dialysate is kept within the peritoneal cavity of a patient.


A “fluid” is a liquid substance optionally having a combination of gas and liquid phases in the fluid. Notably, a liquid, as used herein, can therefore also have a mixture of gas and liquid phases of matter.


A “fluid characteristic” is any sensed characteristic of a fluid, including temperature, pressure, concentration, color, or any other characteristic.


The term “fluid inlet” refers to a conduit or opening through which fluid, gas, or a combination thereof, can enter a component or apparatus.


A “fluid line” can refer to a tubing or conduit through which a fluid, gas, or a combination thereof can pass. The fluid line can also contain air during different modes of operation such as cleaning or purging of a line.


The term “fluid outlet” refers to a conduit or opening through which fluid, gas, or a combination thereof, can exit a component or apparatus.


The term “fluid sensor apparatus” refers to an apparatus through which fluid can be pumped to determine any one of a solute, solute concentration, ion concentration, a pH, or a combination of solutes in the fluid.


The term “fluidly connectable” refers to the ability of providing for the passage of fluid, gas, or combination thereof, from one point to another point. The ability of providing such passage can be any connection, fastening, or forming between two points to permit the flow of fluid, gas, or combinations thereof. The two points can be within or between any one or more of compartments of any type, modules, systems, components, and rechargers.


The term “fluidly connected” refers to a particular state such that the passage of fluid, gas, or combination thereof, is provided from one point to another point. The connection state can also include an unconnected state, such that the two points are disconnected from each other to discontinue flow. It will be further understood that the two “fluidly connectable” points, as defined above, can from a “fluidly connected” state. The two points can be within or between any one or more of compartments, modules, systems, components, and rechargers, all of any type.


To “identify” a particular state or condition means to ascertain whether that state or condition presently exists.


The term “infection” can refer to any virus, bacteria, or pathogen in a patient's tissue. Infections typically occur due to an invasion and multiplication of microorganisms such as bacteria, viruses, and parasites that are not normally present within the body. An infection may cause no symptoms and be subclinical, or it may cause symptoms and be clinically apparent. An infection may remain localized, or it may spread through the blood or lymphatic vessels to become systemic. Microorganisms that live naturally in or on the body may not be considered infections. For example, bacteria that normally live within the mouth and intestine may not be infections depending on an immunity state and health of the body. However, if the body's immunity were to be compromised, the naturally occurring microorganisms may become infectious.


A “light source,” “light emitter,” “photo emitter,” or the like, is any component capable of emitting light at any wavelength including visible, infrared, or ultraviolet light.


A “marker correlated with peritonitis and/or infection” can be any substance, chemical, material, or compound wherein the concentration of the substance, chemical, material, or compound can be used to identify peritonitis and/or an infection in a patient. The marker can be generally found in a bodily fluid.


The terms “opposite,” “opposing,” and “positioned opposedly” refer to relative positions of two or more components wherein the two or more components are positioned substantially on opposite sides to a reference point.


A “patient” or “subject” is a member of any animal species, preferably a mammalian species, optionally a human. The subject can be an apparently healthy individual, an individual suffering from a disease, or an individual being treated for a disease. In certain embodiments, the patient can be a human, sheep, goat, dog, cat, mouse or any other animal.


The term “peritoneal cavity” refers to the space between the parietal peritoneum and visceral peritoneum of a patient.


“Peritoneal dialysate” is a dialysis solution that can be used in peritoneal dialysis having specified parameters for purity and sterility. Peritoneal dialysate is not the same as dialysate used in hemodialysis although peritoneal dialysate may be used in hemodialysis.


A “peritoneal dialysis cycler” can be a component or system for movement of fluid into and out of the peritoneal cavity of a patient. In certain embodiments a peritoneal dialysis cycler can be an integrated cycler, wherein the integrated cycler forms a part of an overall system. For example, the integrated cycler can be contained in a housing with other components used for peritoneal dialysis and be in fluid and electrical connection with desired components. Alternatively, the peritoneal dialysis cycler can be external to systems for generation and disposal of peritoneal dialysate.


The term “peritoneal dialysis cycle” or “cycle” can refer to any one, or combination of infusion of peritoneal dialysate into a patient, a dwell of the peritoneal dialysate within the peritoneal cavity of the patient, and the removal of the peritoneal dialysate from the peritoneal cavity of the patient. The process of filling and then draining your abdomen can be considered an “exchange” of used and clean fluids. However, the number, length, and timing of “cycles” or “exchanges” are nonlimiting. For example, Continuous Ambulatory Peritoneal Dialysis (CAPD) and Continuous Cycling Peritoneal Dialysis (CCPD) may occur on different schedules, but the process of filling and then draining the peritoneal cavity can be referred to as “cycles” for both CAPD and CCPD. As such, the term is “cycle” or exchange refers to any dialysis schedule or type of dialysis.


The term “peritonitis” can refer to an inflammation of the peritoneum.


A “photodetector” is a component capable of detecting light intensity, light composition, or both to result in data, such as an image, of the light detected. The terms “camera” and “photo detector” can also generally refer to any type of detector including an RGB detector or spectrophotometer.


The term “processor” as used is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art. The term refers without limitation to a computer system, state machine, processor, or the like designed to perform arithmetic or logic operations using logic circuitry that responds to and processes the basic instructions that drive a computer. In any embodiment of the first, second, third, and fourth invention, the terms can include ROM (“read-only memory”) and/or RAM (“random-access memory”) associated therewith.


The term “programmed,” when referring to a processor, can mean a series of instructions that cause a processor to perform certain steps.


The term “pump” refers to any device that causes the movement of fluids or gases by applying suction or pressure.


The terms “pumping,” “pumped,” or to “pump” refer moving a fluid, gas, or combination thereof, with a pump.


The term “receiving slot” is a space within a component or apparatus into which a second component or apparatus can be placed.


The term “removing fluid” or to “remove fluid” means to withdraw fluid from a reservoir, container, system, or patient.


The term “sensor card” refers to a rigid and/or planar component having at least one sensing membrane or sensing material of any kind disposed on, inside or integral to the “sensor card.” The sensing membrane or material can contact a fluid and produce a detectable change in response to a fluid characteristic of the fluid.


A “sensor region” or “sensing region” is a portion of a sensor card that undergoes a detectable change in response to a fluid characteristic.


A “side of a sensor card” is any portion of a sensor card having a surface area. The terms “first side” or “second side” as used when referring to a sensor card, are meant to differentiate between two different sides of the sensor card, and are not meant to further limit the shape or position of the sensor card. In certain embodiments, the first side and the second side of the sensor card can be opposite sides.


A “side slot” is an opening in a catheter, positioned on a side of the catheter to promote flow over a catheter slot surface.


The term “upstream” refers to a position of a first component in a flow path relative to a second component wherein fluid will pass by the first component prior to the second component during normal operation. The first component can be said to be “upstream” of the second component, while the second component is “downstream” of the first component.


A “waste reservoir” is a container into which used or unwanted fluids are stored for later disposal.


Peritoneal Dialysis Fluid Testing



FIG. 1 illustrates a peritoneal dialysis cycler with a fluid sensor apparatus 101 for testing peritoneal dialysate effluent. Peritoneal dialysate, which can be generated either by the system or provided in a separated fluid source that is fluidly connectable to the system, is pumped through peritoneal dialysate inlet line 106 by a pump (not shown). The peritoneal dialysate is pumped through valve 108 and cycler line 112 and connector 116 to catheter 105, and then into a patient (not shown). The cycler line 112 can extend from valve 108 to connector 116. A filter 117 can be included to ensure any particulate matter is removed prior to pumping the peritoneal dialysate into the patient. In certain embodiments, one or more additional sensors can be included to sense certain fluid characteristics of the peritoneal dialysate in cycler line 112, including an air detector 113, a flow sensor 114, a pressure sensor 115 and a temperature sensor (not shown). Although shown as sensors arranged in series in FIG. 1, other arrangements of the air detector 113, flow sensor 114, pressure sensor 115 and temperature sensor are contemplated. For example, one or more of the sensors can be arranged in parallel. Alternatively, one or more sensor lines can be included, with a portion of fluid drawn out of the cycler line 112 and passed through any of the sensors. Bypass lines and/or valves can be included to selectively direct the peritoneal dialysate through any of the sensors. Medication, such as heparin, can be added by syringe 118 through fluid line 119. T-junction 121 can provide for medication to flow from fluid line 119 to enter the catheter 105. The T-junction 121 can be replaced by any valve as described herein (not shown) for control over adding medication from syringe 118. After a dwell period the peritoneal dialysate can be removed from the patient through catheter 105 and cycler line 112 back to the valve 108. Pump 103 can provide a driving force for removing fluid from the peritoneal cavity of the patient. Pump 103 can be a bi-directional pump. A bi-directional pump can allow fluid to be pumped from the patient through drain lines 102 and 120 from valve 108 to reservoir 104 or a drain, and also to pump fluid from a reservoir 104 to valve 108.


During draining, valve 108 can be set to direct fluid into drain line 102, which can include valve 107 for fluid control and extend from valve 108 to an optional valve 109. Valve 107 controls the flow of peritoneal dialysate into or out of the drain line 102. Valve 107 can be closed when fluid is being pumped into the cycler line 112 from peritoneal dialysate inlet line 106. Valve 107 can be open when draining fluid from the patient. By selectively opening or closing valve 107, fresh dialysate can be prevented from entering drain line 102. The drain line 102, in certain embodiments, can include optional valve 109, which can selectively direct all or part of the drained peritoneal dialysate through fluid line 110, which includes the fluid sensor apparatus 101. In certain embodiments, only a portion of the spent peritoneal dialysate can be pumped through fluid line 110, with the rest bypassing the fluid line 110 and fluid sensor apparatus 101 through drain line 102. Alternatively, valve 109 can be optional, with the fluid sensor apparatus 101 positioned in the drain line 102 such that all spent peritoneal dialysate passes through the fluid sensor apparatus 101. In other embodiments, an additional bypass line (not shown) can be included, with one or more valves selectively directing fluid through the fluid sensor apparatus 101 or through the bypass line to bypass the fluid sensor apparatus 101 from upstream to downstream of the fluid sensor apparatus 101. Fluid exiting the fluid sensor apparatus 101 can be returned to the drain line 120 through fluid line 111. Drain line 120 can extend from valve 109 to a reservoir 104, or optionally to a drain. In embodiments where the fluid sensor apparatus 101 is in the drain line, the segments of the drain line 102 and 120 can be replaced by a single drain line. The spent dialysate can be pumped to a waste reservoir 104, or alternatively, to a drain (not shown) for disposal. One of skill in the art will understand that the flow path illustrated in FIG. 1 is for illustrative purposes only, and that other arrangement of fluid lines and valves are contemplated by the invention.


As described herein, in certain embodiments the fluid sensor apparatus 101 can include two fluid inlets 124 and 125, and one fluid outlet 126. The two inlets provide an even and complete flow through the fluid sensor apparatus 101. However, a fluid sensor apparatus 101 with a single fluid inlet or with multiple fluid outlets can also be used. Junction 123 can split the peritoneal dialysate in fluid line 110 into two streams, with each stream entering one of the fluid inlets 124 or 125. The fluid outlet 126 is fluidly connectable to fluid line 111, which connects to the drain line 120 at T-junction 122, allowing the fluid sensor apparatus 101 to be isolated from the drain lines 102 and 120.


The catheter 105 can be any type of single or and multi-lumen catheter known in the art. A processor (not shown) can control the timing of sampling of peritoneal dialysate from the patient, as well as identification of peritonitis or infection, as described. The peritoneal dialysate can be pumped through the fluid sensor apparatus 101 during a dwell period of a peritoneal dialysis cycle, or after the dwell period, during a drain portion of the peritoneal dialysis cycle. For example, the processor can be programmed to operate pump 103 and valves 107, 108, and 109 to remove a small amount of peritoneal dialysate from the patient at various times within a peritoneal dialysis cycle and pump the peritoneal dialysate through the fluid sensor apparatus 101. The valves 107, 108, and 109 can one-way, two-way, three-way, or n-way with any desired number of configuration. The sampling can take place at set times during a peritoneal dialysis cycle, such as every 15 minutes. Other set times, such as every 30 minutes, or every hour can also be used. The sampling can occur in any desired interval ranging from every minute to every hour. Other time intervals greater than one hour are contemplated and no restriction on time intervals is imposed. In certain embodiments, the system can allow a user to sample the peritoneal dialysate within the patient on demand. Alternatively, the peritoneal dialysate can be pumped through the fluid sensor apparatus 101 only at the end of a peritoneal dialysis cycle during draining of the peritoneal cavity. Using the fluid sensor apparatus 101 at the end of a peritoneal dialysis cycle may be advantageous because the markers detected by the fluid sensor apparatus 101 may not change rapidly during the intersession time period and the concentrations may be low enough to require testing during the drain portion of the cycle in order to accurately detect the markers.


As described, the fluid sensor apparatus 101 can detect one or more fluid characteristics in the spent peritoneal dialysate drained from the patient. In certain embodiments, the fluid sensor apparatus 101 can detect specific markers correlated with peritonitis or infection. The fluid sensor apparatus 101 can also detect additional fluid characteristics, including the pH of the spent peritoneal dialysate, as well as concentrations of one or more solutes, a color of the peritoneal dialysate, and/or a clarity of the peritoneal dialysate. A processor (not shown) in communication with the fluid sensor apparatus 101 can receive a signal from the fluid sensor apparatus 101 and identify or diagnose the patient with peritonitis and/or infection based on the received signal.



FIGS. 2A-F illustrate a non-limiting embodiment of a fluid sensor apparatus 201. FIG. 2A illustrates a side view of the fluid sensor apparatus 201; FIG. 2B illustrates a perspective view of the fluid sensor apparatus 201; FIG. 2C illustrates a receiving slot cover 212 for the fluid sensor apparatus 201; FIG. 2D illustrates a cut-away portion of the fluid sensor apparatus 201 at a specified depth and a sensor card 209 being inserted into a receiving slot 202 of the fluid sensor apparatus 201; FIG. 2E illustrates a front view of the fluid sensor apparatus 201 with the sensor card 209 inserted; and FIG. 2F illustrates a side view of the fluid sensor apparatus 201.


As shown in FIG. 2D, the fluid sensor apparatus 201 has a receiving slot 202 traversing a sampling chamber 228 along an axis. A removable sensor card 209 can be inserted into the receiving slot 202 as illustrated in FIGS. 2D and 2E to a specified depth of the fluid sensor apparatus 201. Indentations 230 on either side of the sampling chamber 228 at the depth of the fluid sensor apparatus 201 in FIG. 2D, can receive an edge of the sensor card 209, to seat or fasten the sensor card 209 in place. At a higher depth of the fluid sensor apparatus 201, a groove can be formed appurtenant to a sidewall of the sampling chamber 228 to receive a side edge of the sensor card 209. An edge of the sensor card 209 can be securely positioned in the sampling chamber 228 at a specified location or orientation with respect to a light source and/or photodetector. Alternatively, one or more grooves can be formed into the fluid sensor apparatus 201 to receive an edge of the sensor card 209 to securely position the sensor card 209 at a specified location or orientation if the sensor card 209 has a width greater than any axis of the sampling chamber 228 as shown in FIG. 2E.


The sampling chamber 228 can have a plurality of clear windows on the sidewalls as shown in FIG. 3 to provide optical access to the sensor card 209. Holes 229 formed into the body of the fluid sensor apparatus 201 can be used to attach the fluid sensor apparatus 201 to a console or system using screws or other fasteners as shown in FIG. 2D. The sampling chamber 228 extends longitudinally along a length of the receiving slot 202 of the fluid sensor apparatus 201. The receiving slot 202 can extend beyond the sampling chamber 228 and terminate in a fastening mechanism to securely hold the sensor card 209, such as the indentation 230. The sampling chamber 228 can mix fluids to improve fluid contact on the sensor card 209. Notably, the sampling chamber 228 defines a volume such that a front side and a back side of the sensor card 209 can be exposed to fluid flow on both sides of the sensor card 209. The sampled fluid can therefore simultaneously contact a first and second side (or front and back) of the sensor card 209 to advantageously increase the surface area on which fluid contacts sensing membranes in the sensor card 209. The resulting mixing can result in improved sensing of the fluid by the sensor card 209 by making the response of the sensor card 209 to changes in the fluid faster.


The sensor card 209 can have at least one sensing membrane capable of detecting a marker correlated with peritonitis and/or an infection. Further, the sensor card 209 can include a pH sensing membrane to detect a pH of the fluid. The pH sensing membrane, the peritonitis or infection sensing membranes, or both, can change color, optical transmittance, or change emitted fluorescent light intensity or wavelength based on a pH or a concentration of a marker correlated with peritonitis or infection. The sensor card 209 can include a reference sensing region (not shown). The reference sensing region can be used to detect the color and/or clarity of the peritoneal dialysate in addition to, or as an alternative to, any of the other described fluid characteristics. Discolored or cloudy spent peritoneal dialysate can indicate an infection or peritonitis. Detecting the color or clarity of the spent peritoneal dialysate can determine whether the spent peritoneal dialysate includes any blood cells or discoloration, which may indicate peritonitis or infection. The reference sensing region may be a passive reference background color to which the photodetector or camera 206 can accurately detect the color and/or clarity of the fluid. The reference sensing region can be white, or any other solid color that can be detected by the photodetector or camera 206. The processor can compare the wavelength and/or intensity of light from the reference sensing region detected by the photodetector or camera 206 while fluid is pumped through the fluid sensor apparatus 201 as compared to a wavelength and/or intensity of light from the reference sensing region detected by the photodetector or camera 206 when water or any other clear fluid is pumped through the fluid sensor apparatus 201 to determine any changes in the color or clarity of the fluid.


However, the sensor card 209 is not limited to pH, peritonitis, or infection sensing membranes, and can include any colorimetric material producing a detectable change in response to a concentration or other fluid characteristic of a fluid. In general, the colorimetric material can produce any visible change such as change in color or optical transmittance, or a change in emitted fluorescent light intensity or wavelength, wherein the visible change is detected by the photodetector or camera 206 of the present invention. The sensor card 209 can also include only a pH sensing membrane, only a peritonitis or infection sensing membrane, or a sensing membrane having any type of colorimetric material.


As described, the color change of the one or more sensing membranes can be observed through the one or more clear windows positioned on the sidewall of the sampling chamber 228. The sensing membranes can be any material sensitive to a component of the fluid in the fluid path to be sensed. The sensing membrane has a property reacting to a fluid component that causes a detectable change in an optical parameter depending on the concentration of the component in the fluid or any other fluid characteristic. The optical parameter can be any one of color, reflectivity, transitivity fluorescence, adsorption, or any other parameter capable of being optically detected. In a preferred embodiment, the sensing membrane changes color in relationship to changes in the solute concentration of the measured fluid characteristic. For example, the membrane can change color in a first direction along a color spectrum as the solute concentration of the component in the fluid increases, and along a second direction as the solute concentration of the component decreases. The color change of the membrane can be continuous and reversible in response to the component concentration.


An optional temperature probe 222 can determine the temperature of the fluid within the fluid sensor apparatus 201. Along with specified markers, an elevated temperature can indicate an infection. Electrical connector 224 provides the electrical connection from the temperature probe 222 to the fluid sensor apparatus 201.


In FIG. 2F, one non-limiting example of a light source is shown as LED array 231 connected to the system by electrical connector 217. The LED array 231 can shine a light onto a first side of the sensor card 209 seated inside the receiving slot 202. The LED array 231 can direct light through the one or more clear windows in the sidewall of the sampling chamber 228. The light source can be any source of light at any wavelength capable of shining light onto the sensor card 209. In a preferred embodiment, the LED provides white light; however, any color or wavelength of light can be used. In a preferred embodiment, the light source provides uniform backlighting onto one side of the sensor card 209 such that a camera 206 (shown in FIG. 2A) positioned on an opposite side of the fluid sensor apparatus 201 can detect changes on an opposite side of the sensor card 209 via one or more clear windows. However, the LED array 231 can be positioned at any part of the apparatus capable of providing uniform light to the sensor card 209, including direct and side-firing or side-emitting LEDs. Importantly, light can be transmitted through the sensor card 209 and detected on an opposite side on which light is cast. In general, the clear windows for the LED array 231 and camera 206 can be antipodal to each other. The camera 206 can be any appropriate photodetector, spectrophotometer, or photosensor known to those of ordinary skill in the art. The camera 206 can transmit the image or sensed output to a processor for determining the pH and/or identifying the presence of infection or peritonitis and diagnosing the patient. The photodetector or camera 206 can also detect fluorescent light emitted from the sensor card 209. For detection of fluorescent light, an optical bandpass filter can be included in front of the camera 206 to allow the emitted fluorescent light to pass to the camera 206 while blocking any transmitted light from the LED array 231. The camera 206 can detect any change in the light transmitted including the wavelength of light, the mean intensity of light, the variation in intensity of light, and the pixel location in an image produced by the camera 206. Variation in intensity of light and pixel location allow the automatic detection of the sensor membrane position in the image captured by the photodetector or camera 206 for image analysis, making image analysis easier due to the known variations in intensity and location. A second LED array (not shown) or other light source can be included on the same side of the sensor card 209 as the camera 206 for illumination of a barcode or other identification component on the sensor card 209. The second LED array or light source can illuminate the identification component, which can then be read by the camera 206 to ensure the proper sensor card 209 is being used or to obtain data from the barcode or identification component.


In a preferred embodiment, the light is uniformly cast onto the sensor card 209. Such uniform lighting provided by an ordered arrangement of light sources can result in uniform or even backlighting onto the sensor card 209. The luminous intensity of the light on each sensing membrane can also be uniform, meaning that the power of the light emitted by the LED array 231 in each direction to each sensing membrane is uniform. The luminous flux, or the quantity of energy of the light transmitted onto each sensing membrane, can also be uniform, as can the illuminance, or luminous flux per area of the sensing membranes. The uniform lighting can be an ordered array of light sources, or a single homogenous light source that casts even lighting onto a surface. Diffuser films and a light cavity can also be included to provide uniform lighting. Diffuser films are thin films that evenly distribute transmitted light. Non-limiting examples of diffuser films include Brightness Enhancement Film (BEF), Dual Brightness Enhancement Film (DBEF), and Universal Diffuser Film 50 (UDF 50), available from 3M™, a Minnesota corporation. A light cavity is an arrangement of mirrors or other reflectors, such as white surfaces, that form standing waves from light. Advantageously, uniform backlighting can improve accuracy of the sensed color changes on the sensor card 209. The clear windows can be similarly positioned uniformly or in a pattern on the sidewalls to receive the uniform light dispersion. For example, the lights on the LED array 231 can be arranged in any shape, including rectangular, circular, or other shape, to cast light onto the sensor card 209 in a desired dispersion. The sensing membranes can then be positioned on the sensor card 209 to align with light cast by the LED array 231. Further, the power supply for the LED array 231 can provide a stable current and voltage to increase light uniformity.


Although illustrated as opposing the camera 206, the LED array 231 can be positioned anywhere on the fluid sensor apparatus 201, including on any side of the fluid sensor apparatus 201. A light guide can be included to allow light from an LED array 231 positioned on a side of the fluid sensor apparatus 201 to be transmitted through the sensor card 209 and onto the camera 206 along any reflectance pathway. For example, a mirror arrangement can guide light to a photodetector or camera 206 such that the photodetector or camera 206 need not be in directly positioned opposite to the light source. The light guide can provide a reflectance pathway such that the photodetector or camera 206 can be positioned in any convenient location to receive the reflected light. Similarly, the LEDs or any light source can rely on a light guide to direct light such that light sources can be conveniently positioned at any position and need not be opposedly positioned to the photodetector or camera 206. In one embodiment, both the light source and the photodetector or camera 206 transmit and receive light, respectively, using a light guide. The backlight settings can be computer controlled to optimize the backlight for each sensor membrane. The light from the LED array 231 can be set at a first intensity, optimized for a first sensor membrane. The LED can then be switched to a second intensity, optimized for a second sensor membrane. The camera 206 can take an image of each sensor membrane at the optimized backlighting.


In FIGS. 2A and F, the camera 206 and LED array 231 can be placed on opposing sides of the receiving slot 202 to help reduce hot spots formed on the sensor card 209. The light source shown as the LED array 231 and the photo camera described as camera 206 can be positioned opposite to each other on a line or plane that is substantially orthogonal to the receiving slot 202 containing the sensor card 209. A grating light valve (not shown) having an adjustable diffraction grating can be included to control the intensity of light diffracted onto the camera 206. The diffraction grating can be a set of equally spaced, narrow, parallel grates. The grates can disperse the light at different wavelengths, so that light intensity can be measured as a function of a particular wavelength. One or more light diffusive layers can also be included to diffuse the light shining on the sensing material of the sensor card 209 prior to detection by the camera 206. The clear windows can be free from scratches that degrade the sensor performance. In one non-limiting embodiment, to reduce scratches to the clear windows, the windows can be solvent polished. As shown in FIG. 2F, the camera 206 can transmit the image or other sensed output to a processor (not shown) in electronic communication with the camera 206 via electronic link 208.


As described, the processor can determine the color of the pH sensing membrane and/or marker sensing membrane to determine the pH and/or presence of peritonitis or infection, or the concentration of any solutes or ions, in the fluid flowing through the fluid sensor apparatus 201 based on the sensed output. Electronics 207 of FIG. 2A can control the camera 206 and the light source. Although illustrated as having wired communication links between the camera 206, electronics 207, and processor, one of skill in the art will understand that any method of transmitting and receiving data can be used, including Bluetooth, Wi-Fi, or any other methods known in the art. The processor can receive data, and in particular, the image produced by the camera 206, and determine the intensity of the pixels of a particular color in an image of the sensing membranes. The processor can determine the intensity of a specific color of pixels, such as green pixels, in the image produced by the camera 206. However, other colors such as red, blue, or any other suitable color can be used. The definitions of red, green, and blue light can be based on the camera operating software or can be specified by a controller or operating control logic. A spectrophotometer, which measures the wavelength and intensity of the transmitted light can also be used. Advantageously, a spectrophotometer can be more specific to a color of light detected. The processor can then determine the pH, and/or the levels of markers correlated with peritonitis or infection. The processor can use lookup tables, algorithms or any other method for correlating the number of color pixels in the image produced by the camera 206 to a fluid characteristic. The processor can be housed within, or positioned outside of, the fluid sensor apparatus 201. The camera 206 can be operated under manual control or by a software application for controlling the exposure, gain and white balance.


As shown in FIG. 2A, fluid can enter the fluid sensor apparatus 201 through a fluid inlet 203 and into the sampling chamber 228 of FIG. 2D. The fluid contacts the sensor card 209 seated in the receiving slot 202 of the sampling chamber 228. The fluid can then exit the sampling chamber 228 through fluid outlets 204 and 205. The fluid outlets 204 and 205 and the fluid inlet 203 can be both positioned on the same side of the sampling chamber 228 to provide a curved fluid flow path such that fluid can enter through the fluid inlet 203 positioned in between fluid outlets 204 and 205 wherein fluid then flows into a first end of the sampling chamber 228 and flows in a curved flow path and out a second end of the sampling chamber 228 and into the two fluid outlets 204 and 205 positioned on the same side as the sampling chamber 228. Conversely, the two fluid outlets 204 and 205 can be used as inlets to introduce fluid into sampling chamber 228 along a curved flow path such that fluid flows into and out of the fluid inlet 203. One of skill in the art will understand that one or more fluid inlets and outlets can be used. In a preferred embodiment, the two fluid outlets 204 and 205 advantageously improve fluid contact of the sensing membrane of the sensor card 209. Notch 218 on fluid inlet 203, notch 219 on outlet 204, and notch 220 on outlet 205 can provide secured fastening of the fluid inlet 203 and fluid outlets 204 and 205 to tubing as needed.


In FIG. 2C, the receiving slot 202 can include additional components to ensure that the detachable receiving slot cover 212 fits tightly over the receiving slot 202 and does not move as fluid is flowed into and through the sampling chamber 228. As illustrated in FIGS. 2A and 2B, the receiving slot 202 can have an extended portion 210 that will contact the receiving slot cover 212 when closed. The extended portion 210 can include grooves 211 and 214 for receiving pins 213 and 215 when the receiving slot cover 212 is placed over the receiving slot 202. The pins 213 and 215 engage with the grooves 211 to ensure the receiving slot cover 212 is properly placed and securely fastened on the fluid sensor apparatus 201.


To improve accurate measurements, the sensor card 209 can be fixed into a specified position and/or orientation inside the receiving slot 202 to resist any movement due to the flow of the fluid. Any suitable fastener to fix the receiving slot cover 212 to the fluid sensor apparatus 201 is contemplated. Magnets can be placed within the receiving slot cover 212 and the fluid sensor apparatus 201 to determine whether the receiving slot cover 212 is in the proper position. If the receiving slot cover 212 is closed, the magnets can provide a means to determine if receiving slot cover 212 is closed over the receiving slot 202 on the fluid sensor apparatus 201. As shown in FIG. 2F, overhang 216 can provide support for the receiving slot cover 212 when closed. In FIGS. 2D and 2E, opening 226 on extended portion 210 can provide for a fastener to be inserted through the receiving slot cover 212 to secure the receiving slot cover 212 onto the fluid sensor apparatus 201.


In FIG. 2C, an annular bevel 227 can be formed on the receiving slot cover 212 to capture the sensor card 209 and hold the sensor card 209 securely locked in the fluid sensor apparatus 201. Screws 225 fasten the electronics 207 and camera 206 to the fluid sensor apparatus 201. Alternative methods of securing components to the fluid sensor apparatus 201 can be used, including adhesive, glue, bolts, or any other securing components known in the art. Holes 223 allow additional components and electronics to be added to the fluid sensor apparatus 201.



FIG. 3 illustrates a non-limiting embodiment of a sensor card 301 for use with the fluid sensor apparatus. The sensor card 301 can have three sensing membranes containing a colorimetric material. The sensing membranes can include any colorimetric material, including a first sensing membrane 302 for detection of a first marker correlated with peritonitis or infection, a second sensing membrane 303 for detection of a first marker correlated with peritonitis or infection, and a pH sensing membrane 304. The sensor card 301 can also include a reference sensing region 307. One of skill in the art will understand that any number of sensing membranes can be included in the sensor card 301, including 1, 2, 3, 4, 5, 6, or more sensing membranes of any type. Multiple sensing membranes of the same type can provide redundancy and further accuracy. As described, the sensor card 301 can include a hole 305 for equalizing pressure when fluid is flowed across both sides of the sensor card 301. The sensor card 301 can also have at least one tapered edge 306. As described, the tapered edge 306 can fit within a bevel in the receiving slot or receiving slot cover of the fluid sensor apparatus, further fixing the sensor card 301 in place. Although shown as a circular array of sensing regions in FIG. 3, the sensor card 301 can include any type of array of sensing regions, including a linear array of sensing regions, as illustrated with sensor card 209 in FIGS. 2A-F.


As described, the sensor card 301 can include one or more sensing membranes 304 that can be used to detect peritonitis or infection. Non-limiting examples markers correlated with peritonitis or infection include materials that can cause a sensing membrane to produce a visual change include MMP8, IL-6, HNE, MMP2, MMP9, TIMP1, TIMP2, NGAL, A1AT, desmosine, fibrinogen, IL-8, calprotectin, fMLP, IL1 b, cystatin C, HSA, RBP4, SPD, MPO, sICAM and TNFa. One of skill in the art will understand that additional markers can be correlated with peritonitis and infection that may be detected by the described fluid sensor apparatus.


Each of the markers can be detected using an enzyme linked immunosorbent assay (ELISA) technique or any other known technique known to those of ordinary skill. Antigens or capture molecules specific for a marker correlated with peritonitis or infection can be immobilized in a sensing region of the sensor card. A reporter molecule, typically an antibody or fragment or derivative thereof, can be contained in the sensor card. The reporter molecule interacts with the marker if present and bound in the sensor region. The reporter molecule becomes immobilized in the sensor region when the marker is present and can produce a detectable change in the sensor region upon immobilization. As described, the fluid sensor apparatus can detect the change in color, optical transmittance, or change emitted fluorescent light intensity or wavelength resulting from the binding of the reporter molecule, and thereby detect the presence or concentration of the marker in peritoneal dialysate pumped through the fluid sensor apparatus.


As described, any type of peritoneal dialysis catheter can be used with the peritoneal dialysate fluid testing system. One non-limiting example is the Palindrome™ catheter, available from Medtronic Inc., an Irish corporation, illustrated in FIG. 4. A tip 402 of the catheter 401 is inserted into the peritoneal cavity of a patient. As illustrated in FIG. 4, the catheter 401 can be a dual-lumen catheter, with a first lumen 403 for moving fluid into the patient, and a second lumen (not shown in FIG. 4) for removing fluid from the patient. One or more side slots 404 can be present to promote flow over the surface of the catheter 401, minimizing debris attachment and lessening the risk for clot formation. The catheter 401 can be fluidly connectable to a drain line including the fluid sensor apparatus illustrated in FIGS. 1-2. Peritoneal dialysate can be withdrawn from a patient through the catheter 401 and through a drain line to the fluid sensor apparatus for detection and diagnosis of peritonitis or infection.


Although illustrated in FIG. 4 as a dual lumen catheter 401 with side slots 404, one of skill in the art will understand that alternative catheters are contemplated. Further, the system can use a mono-lumen catheter, a tri-lumen catheter or any type of multi-lumen catheter. With tri- or multi-lumen catheters, one of the lumens can be dedicated for sampling to a sensor line, which can contain the fluid sensor apparatus and/or any other described sensors. Any catheter with or without side slots or side holes can be used with the peritoneal dialysate fluid testing system.


It will be apparent to one skilled in the art that various combinations and/or modifications and variations can be made in the dialysis system depending upon the specific needs for operation. Moreover, features illustrated or described as being part of an aspect of the invention can be included in the aspect of the invention, either alone or in combination.

Claims
  • 1. A method, comprising the steps of: pumping a peritoneal dialysate from a peritoneal cavity of a patient through a catheter to a fluid sensor apparatus; anddetecting at least one fluid characteristic of the peritoneal dialysate correlated with peritonitis and/or infection with the fluid sensor apparatus;wherein the fluid sensor apparatus comprises at least one fluid inlet fluidly connected to the catheter and at least two fluid outlets fluidly connected to a second fluid line; wherein fluid is pumped through the fluid sensor apparatus from the at least one fluid inlet to the at least two fluid outlets;a receiving slot for a sensor card; the receiving slot in fluid communication with the at least one fluid inlet and at least two fluid outlets;a light source directing light onto a first side of the sensor card; anda camera or photodetector detecting light on a second side of the sensor card opposite to the first side of the sensor card;wherein the step of detecting at least one fluid characteristic of the peritoneal dialysate comprises the steps of directing light from the light source onto a first side of the sensor card and detecting the light on a second side of the sensor card.
  • 2. The method of claim 1, wherein peritoneal dialysate is pumped from the peritoneal cavity of the patient through the fluid sensor apparatus during a dwell period.
  • 3. The method of claim 1, wherein peritoneal dialysate is pumped from the peritoneal cavity of the patient through the fluid sensor apparatus during a drain portion of a peritoneal dialysis cycle.
  • 4. The method of claim 1, wherein the at least one fluid characteristic is one or more markers correlated with peritonitis and/or infection.
  • 5. The method of claim 4, further comprising the step of diagnosing the patient with peritonitis and/or infection based on the at least one fluid characteristic.
  • 6. The method of claim 5, wherein the step of diagnosing the patient with peritonitis and/or infection is performed by a processor in communication with the fluid sensor apparatus.
  • 7. The method of claim 4, wherein the one or more markers associated with peritonitis and/or infection are selected from a group consisting of MMP8, IL-6, HNE, MMP2, MMP9, TIMP1, TIMP2, NGAL, A1AT, desmosine, fibrinogen, IL-8, calprotectin, fMLP, IL1 b, cystatin C, HSA, RBP4, SPD, MPO, sICAM and TNFa.
  • 8. The method of claim 1, wherein the at least one fluid characteristic of the peritoneal dialysate comprises at least one of a color and a clarity of the fluid.
  • 9. The method of claim 1, wherein the sensor card comprises at least two sensor regions; wherein a first sensor region undergoes a detectable change in response to a first marker correlated with peritonitis and/or infection; and wherein a second sensor region undergoes a detectable change in response to a second marker correlated with peritonitis and/or infection.
  • 10. The method of claim 1, wherein the sensor card comprises at least one passive background reference sensing region.
  • 11. The method of claim 1, further comprising the step of determining a pH of the peritoneal dialysate using the fluid sensor apparatus.
  • 12. The method of claim 1, wherein the step of detecting at least one fluid characteristic comprises detecting any one of a wavelength of light, a mean intensity of light, and/or variation in intensity of light transmitted through a sensor region of the sensor card.
  • 13. The method of claim 1, wherein the step of detecting at least one fluid characteristic comprises detecting any one of a wavelength of light, a mean intensity of light, and/or variation in intensity of light reflected from a sensor region of the sensor card.
  • 14. The method of claim 1, wherein the step of detecting at least one fluid characteristic comprises detecting a fluorescent light intensity or wavelength emitted from a sensor region of the sensor card.
  • 15. The method of claim 1, further comprising the step of determining a concentration of at least one solute in the peritoneal dialysate using the sensor apparatus.
  • 16. The method of claim 15, wherein the solute is a marker associated with peritonitis and/or infection.
  • 17. The method of claim 1, wherein the at least one fluid inlet comprises at least two fluid inlets, wherein each of the at least two fluid outlets fluidly connect the receiving slot to the catheter.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of and priority to U.S. patent application Ser. No. 15/914,791 filed Mar. 7, 2018, a continuation in part of U.S. patent application Ser. No. 15/677,261 filed Aug. 15, 2017, which claims priority to Provisional Patent Application No. 62/385,946 filed Sep. 9, 2016, the entire disclosures of each of which are incorporated by reference herein.

US Referenced Citations (348)
Number Name Date Kind
3602222 Herndon Aug 1971 A
3608729 Haselden Sep 1971 A
3669878 Marantz Jun 1972 A
3669880 Marantz Jun 1972 A
3730183 Goldsmith May 1973 A
3754867 Guenther Aug 1973 A
3850835 Marantz Nov 1974 A
3884808 Scott May 1975 A
3989622 Marantz Nov 1976 A
3989625 Mason Nov 1976 A
4060485 Eaton Nov 1977 A
4371385 Johnson Feb 1983 A
4374382 Markowitz Feb 1983 A
4381999 Boucher May 1983 A
4460555 Thompson Jul 1984 A
4556063 Thompson Dec 1985 A
4562751 Nason Jan 1986 A
4581141 Ash Apr 1986 A
4650587 Polak Mar 1987 A
4661246 Ash Apr 1987 A
4678408 Mason Jul 1987 A
4685903 Cable Aug 1987 A
4747822 Peabody May 1988 A
4750494 King Jun 1988 A
4772560 Attar Sep 1988 A
4799493 DuFault Jan 1989 A
4826663 Alberti May 1989 A
4828693 Lindsay May 1989 A
4976683 Gauthier Dec 1990 A
5032265 Jha Jul 1991 A
5080653 Voss Jan 1992 A
5091642 Chow Feb 1992 A
5092886 Dobos-Hardy Mar 1992 A
5097122 Coiman Mar 1992 A
5127404 Wyborny Jul 1992 A
5141493 Jacobsen Aug 1992 A
5284470 Beltz Feb 1994 A
5302288 Meidl Apr 1994 A
5305745 Zacouto Apr 1994 A
5318750 Lascombes Jun 1994 A
5364593 Mihaylov Nov 1994 A
5415838 Rieger May 1995 A
5468388 Goddard Nov 1995 A
5507723 Keshaviah Apr 1996 A
5643201 Peabody Jul 1997 A
5651893 Kenley Jul 1997 A
5683432 Goedeke Nov 1997 A
5744031 Bene Apr 1998 A
5762782 Kenley Jun 1998 A
5819007 Elghazzawi Oct 1998 A
5902336 Mishkin May 1999 A
5944684 Roberts Aug 1999 A
5987352 Klein Nov 1999 A
6048732 Anslyn Apr 2000 A
6052622 Holmstrom Apr 2000 A
6058331 King May 2000 A
6156002 Polaschegg Dec 2000 A
6230059 Duffin May 2001 B1
6248093 Moberg Jun 2001 B1
6254567 Treu Jul 2001 B1
6321101 Holmstrom Nov 2001 B1
6362591 Moberg Mar 2002 B1
6363279 Ben-Haim Mar 2002 B1
6505075 Weiner Jan 2003 B1
6554798 Mann Apr 2003 B1
6555986 Moberg Apr 2003 B2
6589229 Connelly Jul 2003 B1
6602399 Fromherz Aug 2003 B1
6609023 Fischell Aug 2003 B1
6627164 Wong Sep 2003 B1
6645191 Knerr Nov 2003 B1
6676608 Keren Jan 2004 B1
6689083 Gelfand Feb 2004 B1
6706007 Gelfand Mar 2004 B2
6711439 Bradley Mar 2004 B1
6726647 Sternby Apr 2004 B1
6780322 Bissler Aug 2004 B1
6818196 Wong Nov 2004 B2
6878283 Thompson Apr 2005 B2
6887214 Levin May 2005 B1
6890315 Levin May 2005 B1
6960179 Gura Nov 2005 B2
7074332 Summerton Jul 2006 B2
7077819 Goldau Jul 2006 B1
7131956 Pirazzoli Nov 2006 B1
7175809 Gelfand Feb 2007 B2
7207946 Sirokman Apr 2007 B2
7208092 Micheli Apr 2007 B2
7276042 Polaschegg Oct 2007 B2
7399289 Gelfand Jul 2008 B2
7404799 Koh Jul 2008 B1
7500958 Asbrink Mar 2009 B2
7566432 Wong Jul 2009 B2
7575564 Childers Aug 2009 B2
7610086 Ke Oct 2009 B1
7674231 McCombie Mar 2010 B2
7704361 Garde Apr 2010 B2
7736507 Wong Jun 2010 B2
7744553 Kelly Jun 2010 B2
7754852 Burnett Jul 2010 B2
7756572 Fard Jul 2010 B1
7775983 Zhang Aug 2010 B2
7775986 Roeher Aug 2010 B2
7776210 Rosenbaum Aug 2010 B2
7785463 Bissler Aug 2010 B2
7794141 Perry Sep 2010 B2
7850635 Polaschegg Dec 2010 B2
7857976 Bissler Dec 2010 B2
7867214 Childers Jan 2011 B2
7896831 Sternby Mar 2011 B2
7922686 Childers Apr 2011 B2
7922911 Micheli Apr 2011 B2
7947179 Rosenbaum May 2011 B2
7955291 Sternby Jun 2011 B2
7967022 Grant Jun 2011 B2
7981082 Wang Jul 2011 B2
8000000 Greenberg Aug 2011 B2
8034161 Gura Oct 2011 B2
8070709 Childers Dec 2011 B2
8096969 Roberts Jan 2012 B2
8105260 Tonelli Jan 2012 B2
8202503 Putnam Feb 2012 B2
8183046 Lu May 2012 B2
8187250 Roberts May 2012 B2
8197439 Wang Jun 2012 B2
8202241 Karakama Jun 2012 B2
8246826 Wilt Aug 2012 B2
8273049 Demers Sep 2012 B2
8282828 Wallenas Oct 2012 B2
8292594 Tracey Oct 2012 B2
8313642 Yu Nov 2012 B2
8317492 Demers Nov 2012 B2
8357113 Childers Jan 2013 B2
8366316 Kamen Feb 2013 B2
8366655 Kamen Feb 2013 B2
8404091 Ding Mar 2013 B2
8409441 Wilt Apr 2013 B2
8496809 Roger Jul 2013 B2
8499780 Wilt Aug 2013 B2
8500676 Jansson Aug 2013 B2
8512271 Moissl Aug 2013 B2
8518260 Raimann Aug 2013 B2
8521482 Akonur Aug 2013 B2
8535525 Heyes Sep 2013 B2
8560510 Brueggerhoff Oct 2013 B2
8580112 Updyke Nov 2013 B2
8597227 Childers Dec 2013 B2
8696626 Kirsch Apr 2014 B2
8903492 Soykan Dec 2014 B2
8926542 Gerber Jan 2015 B2
9907897 Burbank Mar 2018 B2
20010048637 Weigl Dec 2001 A1
20020016550 Sweeney Feb 2002 A1
20020042561 Schulman Apr 2002 A1
20020112609 Wong Aug 2002 A1
20030028089 Galley Apr 2003 A1
20030069481 Hervy Apr 2003 A1
20030080059 Peterson May 2003 A1
20030097086 Gura May 2003 A1
20030105435 Taylor Jun 2003 A1
20030113931 Pan Jun 2003 A1
20030114787 Gura Jun 2003 A1
20030187479 Thong Oct 2003 A1
20030216677 Pan Nov 2003 A1
20040019312 Childers Jan 2004 A1
20040060865 Callan Apr 2004 A1
20040068219 Summerton Apr 2004 A1
20040099593 DePaolis May 2004 A1
20040147900 Polaschegg Jul 2004 A1
20040168969 Sternby Sep 2004 A1
20040215090 Erkkila Oct 2004 A1
20050065760 Murtfeldt Mar 2005 A1
20050113796 Taylor May 2005 A1
20050126961 Bissler Jun 2005 A1
20050131331 Kelly Jun 2005 A1
20050126998 Childers Jul 2005 A1
20050150832 Tsukamoto Jul 2005 A1
20050214863 McDevitt Sep 2005 A1
20050234354 Rowlandson Oct 2005 A1
20050234357 Xue Oct 2005 A1
20050234381 Niemetz Oct 2005 A1
20050234534 Rowlandson Oct 2005 A1
20050236330 Nier Oct 2005 A1
20050265895 Kopelman Dec 2005 A1
20050274658 Rosenbaum Dec 2005 A1
20060025661 Sweeney Feb 2006 A1
20060025748 Ye Feb 2006 A1
20060217771 Soykan Feb 2006 A1
20060058731 Burnett Mar 2006 A1
20060191850 Bosetto Aug 2006 A1
20060195064 Plahey Aug 2006 A1
20060226079 Mori Oct 2006 A1
20060241709 Soykan Oct 2006 A1
20060247548 Sarkar Nov 2006 A1
20060264894 Moberg Nov 2006 A1
20070007208 Brugger Jan 2007 A1
20070031972 Attar Feb 2007 A1
20070038138 Gill Feb 2007 A1
20070066928 Lannoy Mar 2007 A1
20070073168 Zhang Mar 2007 A1
20070138011 Hofmann Jun 2007 A1
20070161113 Ash Jul 2007 A1
20070175827 Wariar Aug 2007 A1
20070179431 Roberts Aug 2007 A1
20070213653 Childers Sep 2007 A1
20070215545 Bissler Sep 2007 A1
20070222992 Oda Sep 2007 A1
20070255250 Moberg Nov 2007 A1
20070276270 Tran Nov 2007 A1
20080006570 Gura Jan 2008 A1
20080021337 Li Jan 2008 A1
20080053905 Brugger Mar 2008 A9
20080067132 Ross Mar 2008 A1
20080093276 Roger Apr 2008 A1
20080200866 Prisco Aug 2008 A1
20080215247 Tonelli Sep 2008 A1
20080233008 Sarkisov Sep 2008 A1
20080253427 Kamen Oct 2008 A1
20090020471 Tsukamoto Jan 2009 A1
20090036825 Petersen Feb 2009 A1
20090101577 Fulkerson Apr 2009 A1
20090124869 Hu May 2009 A1
20090124963 Hogard May 2009 A1
20090127193 Updyke May 2009 A1
20090149776 Adams Jun 2009 A1
20090171261 Sternby Jul 2009 A1
20090264776 Vardy Oct 2009 A1
20090275849 Stewart Nov 2009 A1
20090275883 Chapman Nov 2009 A1
20090281484 Childers Nov 2009 A1
20090282980 Gura Nov 2009 A1
20090314063 Sternby Dec 2009 A1
20100004588 Yeh Jan 2010 A1
20100010425 Yu Jan 2010 A1
20100010429 Childers Jan 2010 A1
20100042035 Moissl Feb 2010 A1
20100061892 Flaim Mar 2010 A1
20100076398 Scheurer Mar 2010 A1
20100078381 Merchant Apr 2010 A1
20100078387 Wong Apr 2010 A1
20100084330 Wong Apr 2010 A1
20100087771 Karakama Apr 2010 A1
20100094158 Solem Apr 2010 A1
20100113891 Barrett May 2010 A1
20100114012 Sandford May 2010 A1
20100137693 Porras Jun 2010 A1
20100137782 Jansson Jun 2010 A1
20100168546 Kamath Jul 2010 A1
20100217180 Akonur Aug 2010 A1
20100217181 Roberts Aug 2010 A1
20100224492 Ding Sep 2010 A1
20100234795 Wallenas Sep 2010 A1
20100241045 Kelly Sep 2010 A1
20100264086 Noack Oct 2010 A1
20100312172 Hoffman Dec 2010 A1
20110017665 Updyke Jan 2011 A1
20110048949 Ding et al. Mar 2011 A1
20110066006 Banet Mar 2011 A1
20110066043 Banet Mar 2011 A1
20110071465 Wang Mar 2011 A1
20110077574 Sigg Mar 2011 A1
20110077575 Kraemer Mar 2011 A1
20110079558 Raimann Apr 2011 A1
20110081728 Putnam Apr 2011 A1
20110087187 Beck Apr 2011 A1
20110100909 Stange May 2011 A1
20110106003 Childers May 2011 A1
20110130666 Dong Jun 2011 A1
20110137136 Kotanko Jun 2011 A1
20110141116 Dalesch Jun 2011 A1
20110144570 Childers Jun 2011 A1
20110184340 Tan Jul 2011 A1
20110208105 Brandl Aug 2011 A1
20110272337 Palmer Nov 2011 A1
20110301447 Park Dec 2011 A1
20110301472 Grober Dec 2011 A1
20120016228 Kroh Jan 2012 A1
20120029937 Neftel Feb 2012 A1
20120083729 Childers Apr 2012 A1
20120085707 Beiriger Apr 2012 A1
20120115248 Ansyln May 2012 A1
20120135396 McDevitt May 2012 A1
20120181230 Kloeffel Jul 2012 A1
20120220528 VanAntwerp Aug 2012 A1
20120258545 Ash Oct 2012 A1
20120258546 Marran Oct 2012 A1
20120259276 Childers Oct 2012 A1
20120273354 Soykan Nov 2012 A1
20120273415 Gerber Nov 2012 A1
20120273420 Gerber Nov 2012 A1
20120277546 Soykan Nov 2012 A1
20120277551 Gerber Nov 2012 A1
20120277552 Gerber Nov 2012 A1
20120277604 Gerber Nov 2012 A1
20120277650 Gerber Nov 2012 A1
20120277655 Gerber Nov 2012 A1
20120277722 Gerber Nov 2012 A1
20120283581 Olde et al. Nov 2012 A1
20120303079 Mahajan Nov 2012 A1
20130037465 Heyes Feb 2013 A1
20130062265 Balschat Mar 2013 A1
20130116578 QiAn May 2013 A1
20130168316 Noguchi Jul 2013 A1
20130186759 Lin Jul 2013 A1
20130193073 Hogard Aug 2013 A1
20130199998 Kelly Aug 2013 A1
20130211730 Wolff Aug 2013 A1
20130213890 Kelly Aug 2013 A1
20130228517 Roger Sep 2013 A1
20130231607 Roger Sep 2013 A1
20130248426 Pouchoulin Sep 2013 A1
20130274642 Soykan Oct 2013 A1
20130324915 Britton Dec 2013 A1
20130330208 Ly Dec 2013 A1
20130331774 Farrell Dec 2013 A1
20140018727 Burbank Jan 2014 A1
20140018728 Plahey Jan 2014 A1
20140042092 Akonur Feb 2014 A1
20140065950 Mendelsohn Mar 2014 A1
20140088442 Soykan Mar 2014 A1
20140110340 White Apr 2014 A1
20140110341 White Apr 2014 A1
20140158538 Collier Jun 2014 A1
20140158588 Pudil Jun 2014 A1
20140158623 Pudil Jun 2014 A1
20140190876 Meyer Jul 2014 A1
20140216250 Meyer Aug 2014 A1
20140217028 Pudil Aug 2014 A1
20140217029 Meyer Aug 2014 A1
20140217030 Meyer Aug 2014 A1
20140220699 Pudil Aug 2014 A1
20140276100 Satterfield Sep 2014 A1
20140314625 Clift Oct 2014 A1
20150032023 Soykan Jan 2015 A1
20150080682 Gerber Mar 2015 A1
20150088047 Gerber Mar 2015 A1
20150144539 Pudil May 2015 A1
20150148697 Burnes May 2015 A1
20150149096 Soykan May 2015 A1
20150250427 Soykan Sep 2015 A1
20150343126 Merchant Dec 2015 A1
20150352269 Gerber Dec 2015 A1
20150367054 Gerber Dec 2015 A1
20160023467 Smith Feb 2016 A1
20160143774 Burnett May 2016 A1
20160206801 Gerber Jul 2016 A1
20160331884 Sigg Nov 2016 A1
20180043080 Gerber Feb 2018 A1
Foreign Referenced Citations (158)
Number Date Country
3006157 Jan 2017 CA
1643368 Jul 2005 CN
1811380 Aug 2006 CN
101193667 Jun 2008 CN
101300476 Nov 2008 CN
101400997 Jan 2009 CN
101482572 Jul 2009 CN
101726465 Jun 2010 CN
202048893 Mar 2011 CN
103037917 Apr 2013 CN
103180712 Jun 2013 CN
103439230 Sep 2013 CN
103339503 Oct 2013 CN
103803479 May 2014 CN
103901025 Jul 2014 CN
104685342 Jun 2015 CN
104833635 Aug 2015 CN
105008893 Oct 2015 CN
105115921 Dec 2015 CN
105928939 Jul 2016 CN
106124491 Nov 2016 CN
101644667 Feb 2020 CN
3224823 Jan 1984 DE
0266795 Nov 1987 EP
0402505 Dec 1990 EP
0272414 Oct 1991 EP
0330892 Jul 1994 EP
1175238 Nov 2000 EP
1085295 Nov 2001 EP
1281351 Feb 2003 EP
2308526 Oct 2003 EP
1364666 Nov 2003 EP
1523347 Jan 2004 EP
1523350 Jan 2004 EP
0906768 Feb 2004 EP
1691863 Apr 2005 EP
2116269 Feb 2008 EP
1450879 Oct 2008 EP
1514562 Apr 2009 EP
2219703 May 2009 EP
1592494 Jun 2009 EP
2398529 Nov 2010 EP
2575827 Dec 2010 EP
2100553 Aug 2011 EP
2576453 Dec 2011 EP
2701580 Nov 2012 EP
2701595 Nov 2012 EP
1345856 Mar 2013 EP
2344220 Apr 2013 EP
1351756 Jul 2013 EP
2190498 Jul 2013 EP
2701596 Mar 2014 EP
1582226 Jan 2016 EP
S55138462 Oct 1980 JP
S63-143077 Nov 1987 JP
2002533170 Oct 2002 JP
2002542900 Dec 2002 JP
2003235965 Aug 2003 JP
2005-533573 Nov 2005 JP
5-99464 Oct 2012 JP
1995003839 Feb 1995 WO
WO 1998054563 Dec 1998 WO
WO1999006082 Feb 1999 WO
9937342 Jul 1999 WO
PCT1124599 May 2000 WO
0057935 Oct 2000 WO
200066197 Nov 2000 WO
2000066197 Nov 2000 WO
200170307 Sep 2001 WO
2001085295 Sep 2001 WO
0185295 Nov 2001 WO
2002013691 Feb 2002 WO
WO 20020053211 Jul 2002 WO
2003043677 May 2003 WO
2003043680 May 2003 WO
2003051422 Jun 2003 WO
2004008826 Jan 2004 WO
2004009156 Jan 2004 WO
2004009158 Jan 2004 WO
2004030716 Apr 2004 WO
2004030717 Apr 2004 WO
2004064616 Aug 2004 WO
2005033701 Apr 2005 WO
2005061026 Jul 2005 WO
2005123230 Dec 2005 WO
2006011009 Feb 2006 WO
2006017446 Feb 2006 WO
2007038347 Apr 2007 WO
2007089855 Aug 2007 WO
20070115321 Oct 2007 WO
WO2009094035 Jan 2008 WO
2008037410 Apr 2008 WO
2009026603 Dec 2008 WO
2009024566 Feb 2009 WO
2009061608 May 2009 WO
2009094184 Jul 2009 WO
2009157877 Dec 2009 WO
2009157878 Dec 2009 WO
WO2009154955 Dec 2009 WO
WO 20090154955 Dec 2009 WO
WO 20100002830 Jan 2010 WO
2010024963 Mar 2010 WO
2010028860 Mar 2010 WO
2010033314 Mar 2010 WO
2010033699 Mar 2010 WO
2010077851 Jul 2010 WO
2010096659 Oct 2010 WO
2010121820 Oct 2010 WO
2011025705 Mar 2011 WO
2011026645 Mar 2011 WO
WO2013022760 Aug 2011 WO
WO 2011132046 Oct 2011 WO
2011137693 Nov 2011 WO
WO2011161056 Dec 2011 WO
2012042323 Apr 2012 WO
2012050781 Apr 2012 WO
2012051996 Apr 2012 WO
2012073420 Jul 2012 WO
WO 2012129501 Sep 2012 WO
2012148781 Nov 2012 WO
2012148784 Nov 2012 WO
2012148786 Nov 2012 WO
2012148787 Nov 2012 WO
2012148789 Nov 2012 WO
2012162515 Nov 2012 WO
WO2012148788 Nov 2012 WO
WO 20120148784 Nov 2012 WO
2012172398 Dec 2012 WO
2013019179 Feb 2013 WO
2013019994 Feb 2013 WO
2013025844 Feb 2013 WO
2013028809 Feb 2013 WO
2013101292 Jul 2013 WO
2013103607 Jul 2013 WO
2013103906 Jul 2013 WO
2013110906 Aug 2013 WO
2013110919 Aug 2013 WO
2013114063 Aug 2013 WO
2013121162 Aug 2013 WO
2013140346 Sep 2013 WO
2013141896 Sep 2013 WO
14066254 May 2014 WO
14066255 May 2014 WO
14077082 May 2014 WO
2014121162 Aug 2014 WO
2014121163 Aug 2014 WO
2014121167 Aug 2014 WO
2014121169 Aug 2014 WO
WO2014121161 Aug 2014 WO
WO 20140121161 Aug 2014 WO
WO 20140121169 Aug 2014 WO
WO2015081221 Jun 2015 WO
WO 20150130205 Sep 2015 WO
WO 20150159280 Oct 2015 WO
WO 20160080883 May 2016 WO
WO 20170034452 Mar 2017 WO
WO 2017176687 Oct 2017 WO
WO 2017176701 Oct 2017 WO
Non-Patent Literature Citations (160)
Entry
PCTUS2017025876 International Search Report dated Jun. 29, 2017.
PCTUS2017025876 Written Opinion dated Jun. 29, 2017.
Schmitt, et al, “Colorimetric Gas Sensing with Enhanced Sensitivity,” Procedia Engineering, vol. 168, Sep. 3, 2016, pp. 1237-1240.
Wollenstein, et al, “Colorimetric gas sensors for the detection of ammonia, nitrogen dioxide, and carbon monoxide: current status and research trends”, Sensor and Test Conference 2011, Jan. 2, 2011, pp. 562-567.
Written Opinion in Dutch App. No. 2018577, dated Nov. 2, 2017.
€œResources, environment and sustainable development of agriculture,― edited by LIU Zhaopu, China Agricultural Science and Technology Press, pp. 209-211, Aug. 31, 1994.
€œRural Medical and Health Handbook,― written by Shanghai “Rural Medical and Health Handbook Writing team, Shanghai Science and Technology Press, Jun. 1968, p. 435.
€œSurface water environmental quality standard non-ionic ammonia conversion method,―Teng Enjiang, et al., “China Environmental Monitoring, ―vol. 11, No. 4, pp. 7-9, Dec. 31, 1995.
European Search Report for App. No. 19764587.2, dated Nov. 18, 2021.
[NPL105] Brynda, et. al., The detection Ottoman 2-microglcbuiin by grating coupler immunosensor with three dimensional antibody networks. Biosensors & Bioelectronics, 1999, 363-368, 14(4).
[NPL10] Wheaton, et al., Dowex Ion Exchange Resins-Fundamentals of Ion Exchange; Jun. 2000, pp. 1-9. http://www.dow.com/scripts/litorder.asp?filepath=liquidseps/pdfs/noreg/177-01837.pdf.
[NPL111] Zhong, et. al., Miniature urea sensor based on H(+)-ion sensitive field effect transistor and its application in clinical analysis, Chin. J. Biotechnol., 1992, 57-65. 8(1).
[NPL119] PCT/US2012/034331, International Search Report and Written Opinion dated Jul. 9, 2012.
[NPL121] Roberts M, The regenerative dialysis (REDY) sorbent system. Nephrology, 1998, 275-278:4.
[NPL142] Hemametrics, Crit-Line Hematocrit Accuracy, 2003, 1-5, vol. 1, Tech Note No. 11 (Rev. D).
[NPL144] Weissman, S., et al., Hydroxyurea-induced hepatitis in human immunodeficiency virus-positive patients. Clin. Infec. Dis, (Jul. 29, 1999): 223-224.
[NPL146] PCT/US2012/034334, International Search Report, dated Jul. 6, 2012.
[NPL147] PCT/US2012/034335, International Search Report, dated Sep. 5, 2012.
[NPL148] PCT/US/2012/034327, International Search Report, dated Aug. 13, 2013.
[NPL149] PCT/US/2012/034329, International Search Report, dated Dec. 3, 2012.
[NPL14] Foley, et al., Long Interdialytic Interval and Martality among Patients Receiving Hemodialysis, N Engl Jml Med. 2011:365(12):1099-1107.
[NPL15] PCT International Search Report from International Application No. PCT/US2014/067650, dated Mar. 9, 2015.
[NPL169] Wang, Fundamentals of intrathoracic impedance monitoring in heart failure, Am. J. Cardiology, 2007, 3G-10G: Suppl.
[NPL16] PCT/US2014/067650 International Search Report Written Opinion dated Mar. 9, 2015.
[NPL170] Bleyer, et al, Kidney International. Jun. 2006; 69(12):2268-2273.
[NPL176] Bleyer, et. al., Sudden and cardiac death rated in hemodialysis patients, Kidney International. 1999, 1553-1559: 55.
[NPL180] PCT/US2012/034335, International Preliminary Report on Patentability, dated Oct. 29, 2013.
[NPL181] PCT/US2012/034303, Internationa Search Report, dated Jul. 6, 2013.
[NPL186] PCT/US2012/034332, Internatonal Preliminary Report on Patentability, dated Oct. 29, 2013.
[NPL187] PCT/US2012/034333, International Preliminary Report on Patentability, dated Oct. 29, 2013.
[NPL188] PCT/US2012/034333, International Search Report, dated Aug. 29, 2012.
[NPL195] PCT/US2012/034327, International Preliminary Report on Patentability, dated Oct. 29, 2013.
[NPL197] PCT/US2012/034330, International Preliminary Report on Patentability, dated Oct. 29, 2013.
[NPL205] Culleton, BF et al. Effect of Frequent Nocturnal Hemodialysis vs. Conventional Hemodialysis on Left Ventricular Mass and Quality of Life. 2007 Journal of the American Medical Association 298 (11), 1291-1299.
[NPL230] Redfield, et. al, Restoration of renal response to atria! natriuretic factor in experimental low-output heat failure, Am. J. Physiol., Oct. 1, 1989, R917-923:257.
[NPL231] Rogoza, et al., Validation of A&D UA-767 device for the self-measurement of blood pressure, Blood Pressure Monitoring, 2000, 227-231, 5(4).
[NPL233] PCT/US2012/034329, International Preliminary Report on Patentability, dated Oct. 29, 2013.
[NPL234] Lima, et. al., An electrochemical sensor based on nanostructure hollsndite-type manganese oxide for detection of potassium ion, Sensors, Aug. 24, 2009, 6613-8625, 9.
[NPL235] MacLean, et, al., Effects of hindlimb contraction on pressor and muscle interstitial metabolite responses in the cat, J. App. Physiol., 1998, 1583-1592, 85(4).
[NPL238] PCT Application, PCT/US2013/020404, filed Jan. 4, 2013.
[NPL264] PCT/US2014/014357 International Search Report and Written Opinion dated May 19, 2014.
[NPL268] Ronco et al. 2008, Cardiorenal Syndrome, Journal American College Cardiology, 52:1527-1539, Abstract.
[NPL26] Overgaard, et. al., Activity-induced recovery of excitability in K+-depressed rat soleus muscle, Am. J. P 280: R48-R55, Jan. 1, 2001.
[NPL27] Overgaard et. al., Relations between excitability and contractility in rate soleusmuscle: role of the NA+-K+ pump and NA+-K-S gradients. Journal of Physiology, 1999, 215-225, 518(1).
[NPL285] Zoccali, Pulmonary Congestion Predicts Cardiac Events and Mortality in ESRD, Clinical Epidemiology, J. Am Soc Nephrol 24:639-646, 2013.
[NPL306] Coast, et al. 1990, An approach to Cardiac Arrhythmia analysis Using Hidden Markov Models, IEEE Transactions on Biomedical Engineering. 1990, 37(9):826-835.
[NPL309] Weiner, et. al., Article: Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease, Book: Primer on Kidney Diseases (Author: Greenberg, et al), 2009,499-505, 5th Ed., Saunders Elsevier, Philadelphia, PA.
[NPL322] Velasco, Optimal Fluid Control can Normalize Cardiovascular Risk Markers and Limit Left Ventricular Hypertrophy in Thrice Weekly Dialysis Patients, Hemodialysis Intenational, 16:465-472, 2012.
[NPL323] Whitman, CKD and Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapeutic Approaches, J Am Soc Nephrol, 23:1929-1939, 2012.
[NPL324] Hall, Hospitalization for Congestive Heart Failure: United States, 2000-2010, NCHS Data Brief, No. 108, Oct. 2012.
[NPL325] Albert, Fluid Management Strategies in Heart Failure, Critical Care Nurse, 32:20-32, 2012.
[NPL326] PCT/US2014/065201 International Search Report dated May 26, 2015.
[NPL328] Genovesi, et al., Nephrology, Dialysis, Transplantation 2009; 24(8):2529-2536.
[NPL32] Secemsky, et. al, High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients. Heart Rhythm, Apr. 2011, 592-598 : vol. 8, No. 4.
[NPL35] Wei, et. al., Fullerene-cryptand coated piezoelectric crystal urea sensor based on urease, Analytics Chimica Acta, 2001,77-85:437.
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 1-140.
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 141-280.
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 281-420.
[NPL376] Gambro AK 96 Dialysis Machine Operators Manual, Dec. 2012. p. 421-534.
[NPL383] Leifer et al., A Study on the Temperature Variation of Rise Velocity for Large Clean Bubbles, J. Atmospheric & Oceanic Tech., vol. 17, pp. 1392-1402, Oct. 2000.
[NPL384] Talaia, Terminal Velocity of a Bubble Rise in a Liquid Column, World Acad. of Sci., Engineering & Tech., vol. 28, pp. 264-268, Published Jan. 1, 2007.
[NPL386] The FHN Trial Group. In-Center. Hemodialysis Six Times per Week versus Three Times per Week, New England Journal of Medicine, 2010 Abstract.
[NPL39] PCT/US2012/034332, International Search Report, dated Jul. 5, 2012.
[NPL46] Siegenthaler, et al., Pulmonary fluid status monitoring with intrathoracic impedance, Journal of Clinical Monitoring and Computing, 24:449-451, published Jan. 12, 2011.
[NPL477] Office Action in U.S. Appl. No. 13/757,792 dated Apr. 6, 2015.
[NPL483] Office Action in U.S. Appl. No. 13/424,525 dated Aug. 11, 2015.
[NPL486] Office Action in U.S. Appl. No. 13/424,525 dated Oct. 20, 2016.
[NPL494] John Wm Agar: Review: Understanding sorbent dialysis systems, Nephrology, vol. 15, No. 4, Jun. 1, 2010, pp. 406-411.
[NPL495] European Office Action in Application 12717020.7 dated Sep. 14, 2016.
[NPL500] Office Action in U.S. Appl. No. 14/554,272 dated Aug. 8, 2016.
[NPL501] Office Action in U.S. Appl. No. 13/424,467 dated Oct. 16, 2013.
[NPL502] Office Action in U.S. Appl. No. 13/424,467 dated Mar. 3, 2014.
[NPL503] Office Action in U.S. Appl. No. 13/424,490 dated Oct. 22, 2013.
[NPL504] Office Action in U.S. Appl. No. 13/424,490 dated Mar. 10, 2014.
[NPL505] Office Action in U.S. Appl. No. 13/424,490 dated Jul. 14, 2014.
[NPL506] Office Action in U.S. Appl. No. 13/424,490 dated Dec. 5, 2014.
[NPL507] Office Action in U.S. Appl. No. 13/424,525 dated Sep. 29, 2014.
[NPL508] Office Action in U.S. Appl. No. 13/424,525 dated May 6, 2015.
[NPL509] Office Action in U.S. Appl. No. 13/424,454 dated Oct. 17, 2013.
[NPL510] Office Action in U.S. Appl. No. 13/424,454 dated Mar. 10, 2014.
[NPL511] Office action in U.S. Appl. No. 13/424,429 dated Oct. 15, 2015.
[NPL512] Office Action in U.S. Appl. No. 12/571,127 dated Feb. 27, 2014.
[NPL513] Office Action in U.S. Appl. No. 12/571,127 dated Jul. 6, 2015.
[NPL514] Office Action in U.S. Appl. No. 12/571,127 dated Dec. 17, 2015.
[NPL521] Office Action in U.S. Appl. No. 14/554,338 dated Jun. 7, 2016.
[NPL522] Office Action in U.S. Appl. No. 14/554,338 dated Sep. 28, 2016.
[NPL524] Office Action in U.S. Appl. No. 13/424,429 dated Oct. 15, 2015.
[NPL525] Office Action in U.S. Appl. No. 12/571,127 dated Feb. 27, 2014.
[NPL526] Office Action in U.S. Appl. No. 12/571,127 dated Jul. 6, 2015.
[NPL527] Office Action in U.S. Appl. No. 12/571,127 dated Dec. 17, 2015.
[NPL539] Office Action in U.S. Appl. No. 12/571,127 dated Nov. 8, 2012.
[NPL540] Office Action in U.S. Appl. No. 14/554,338 dated Jun. 7, 2016.
[NPL541] Office Action in U.S. Appl. No. 14/554,338 dated Sep. 28, 2016.
[NPL542] Office Action in U.S. Appl. No. 14/554,272 dated Aug. 8, 2016.
[NPL543] Office Action in U.S. Appl. No. 13/424,479 dated Oct. 25, 2014.
[NPL545] Office Action in U.S. Appl. No. 14/566,686 dated Apr. 28, 2016.
[NPL547] Office Action in Chinese Application No. 201510511657.9 dated Dec. 28, 2016.
[NPL582] Office Action in U.S. Appl. No. 13/757,792 dated Apr. 6, 2015.
[NPL632] Lakerveld et al, Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behavior program aimed at lifestyle changes in people at risk: Design of a randomized controlled trial, 2008, BMC Endocrine Disorders, 8(6): 1-19.
[NPL633] Gordhandas et al, Real-Time Extraction and Analysis of Key Morphological Features in the Electrocardiogram, for Data Compression and Clinical Decision Support, 2004, Computational Physiology, pp. 15-18.
[NPL671] European Office Action in Application 12717020.7 dated Dec. 11, 2015.
[NPL672] PCT/US2012/034331 International Preliminary Reporton Patentability and Written Opinion dated Oct. 29, 2013.
[NPL674] Office Action in Chinese Application No. 201280020932.1 dated Jan. 7, 2015.
[NPL675] Office Action in Chinese Application No. 201280020932.1 dated Apr. 3, 2015.
[NPL693] PCT/US2012/034330, International Search Report and Written Opinion dated Aug. 28, 2012.
[NPL699] Office Action in Chinese Application No. 201280020937.4 dated Mar. 22, 2016.
[NPL700] Office Action in Japanese Application No. 2014-508434 dated Nov. 16, 2015.
[NPL701] Office Action in Japanese Application No. 2014-508434 dated Dec. 8, 2014.
[NPL702] Office Action in Japanese Application No. 2014-508434 dated Nov. 4, 2016.
[NPL703] Office Action in European Application No. 12717019.9 dated Feb. 16, 2017.
[NPL706] Office Action in Chinese Application No. 201510511657.9 dated May 10, 2017.
[NPL709] PCT/US2014/065201 International Preliminary Report on Patentability dated May 19, 2016.
[NPL727] Office Action in European Application No. EP 12717021.5 dated Feb. 3, 2017.
[NPL735] Office Action in Chinese Application No. 201510593695.3 dated Jul. 12, 2017.
[NPL748] Office Action in European Application No. EP 12719170.8 dated Jan. 14, 2015.
[NPL749] Office Action in Japanese Application No. JP 2014-508437 dated Dec. 8, 2014.
[NPL90] Nedelkov, et. al., Design of buffer exchange surfaces and sensor chips for biosensor chip mass spectrometry, Proteomics, 2002, 441-446, 2(4).
[NPL] European Search Report App 14865374.4, dated Jun. 12, 2017.
[NPL] European Search Report for Application No. 14865128.4 dated Jun. 20, 2017.
[NPL] Green et al., Sudden Cardiac Death in Hemodialysis Patients: an In-Depth Review , Am J Kidney Dis 57(6)921:929; published Apr. 18, 2011.
[NPL] Rajan et al. Generalized Feature Extraction for Time-Varying Autoregressive Models, IEEE Transacion Signal Processing vol. 44, No. 10; published Oct. 1, 1996.
AU Examiners Report for Application No. 2017246829, dated Jan. 9, 2021.
Castellanos, et al, Clinical Relevance of Intraperitoneal Pressure in Peritoneal Dialysis Patients, Perit Dial Int. Sep.-Oct. 2017;37(5):562-567. doi:10.3747/pdi.2016.00267. Epub Jul. 11, 2017.
Chinese Office Action for App. No. 201710778666.3, dated Feb. 25, 2020.
Chinese Office Action for App. No. 201710778666.3, dated Jul. 15, 2020.
Chinese Office Action for App. No. 201710778666.3, dated Nov. 20, 2020.
Chinese Office Action for App. No. 201710779349.3, dated Jun. 1, 2020.
Chinese Office Action for App. No. 201710779964.4, dated Apr. 14, 2020.
Chinese Office Action for App. No. 201710779964.4, dated Aug. 26, 2020.
Chinese Office Action for App. No. 2019071601874110, dated Jul. 19, 2019.
Chinese Office Action in App. No. 201480059332.5, dated Mar. 30, 2018.
Dejardin, et al, Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications, Nephrol Dial Transplant. May 2007;22(5):1437-44.
European Office Action for App. No. 17190053.3, dated Sep. 18, 2019.
European Search for App. No. 17190081.4, dated Feb. 5, 2021.
European Search Report for App. No. 17185636.2, dated Mar. 27, 2018.
European Search Report for App. No. 14859115.9, dated Jan. 5, 2018.
European Search Report for App. No. 17185636.2 dated Jan. 10, 2018.
European Search Report for App. No. 17185638.8, dated Dec. 19, 2017.
European Search Report for App. No. 17185808.7, dated Jan. 2, 2018.
European Search Report for App. No. 17185810.3, dated Dec. 15, 2017.
European Search Report for App. No. 17190053.3, dated Jan. 2, 2018.
European Search Report for App. No. 17190066.5, dated Jan. 16, 2018.
European Search Report for App. No. 17190081.4, dated Sep. 16, 2019.
European Search Report for App. No. 17190084.8, dated Feb. 9, 2018.
Henderson, et al, “Online Preparation of Sterile Pyrogen-Free Electrolyte Solution,” Trans. Am. Soc. Artif.Intern.Organs, 1978 pp. 465-467.
Indian OA of Nov. 21, 2019 in 2981/KOLNP/2013.
International Preliminary Report on Patentability for App. No. PCT/US2019/019334, dated Jun. 12, 2019.
Laurent, Jeanpierre, “Continuous Monitoring of Dynamic Systems: Application to Monitoring of Dialyzed Patients” Oct. 30, 2004, received from internet: http://laurent.jeanpierre1.free.fr/recherche/papiers/aista2004.pdf.
Office Action for Chinese Application No. 201710779349.3, dated Oct. 9, 2019.
Office Action for European App. No. 17190066.5, dated Mar. 7, 2019.
Office Action in Chinese App. No. 201710778666.3 dated Sep. 19, 2019.
PCT/US2016/058579 International Search Report dated Jan. 31, 2017.
PCT/US2016/058579 Written Opinion dated Jan. 31, 2017.
PCT/US2017/025868 International Search Report dated Jun. 29, 2017.
PCT/US2017/025868 Written Opinion dated Jun. 29, 2017.
PCT/US2017/030377 International Search Report dated Sep. 1, 2017.
PCT/US2017/030377 Written Opinion dated Sep. 1, 2017.
PCTUS20170146199 ISR and written opinion, dated Feb. 19, 2018.
PCTUS2017025858 International Search Report dated Jun. 29, 2017.
PCTUS2017025858 Written Opinion dated Jun. 29, 2017.
Related Publications (1)
Number Date Country
20210220541 A1 Jul 2021 US
Provisional Applications (1)
Number Date Country
62385946 Sep 2016 US
Continuations (1)
Number Date Country
Parent 15914791 Mar 2018 US
Child 17201569 US
Continuation in Parts (1)
Number Date Country
Parent 15677261 Aug 2017 US
Child 15914791 US